VARIABILITY IN GLYCATED HEMOGLOBIN VALUES AND CARDIOVASCULAR EVENTS IN PATIENTS WITH TYPE 2 DIABETES AND MULTIVESSEL CORONARY ARTERY DISEASE

被引:1
|
作者
Rezende, Paulo
Hueb, Whady
Hlatky, Mark
Garcia, Rosa
Garzillo, Cibele
Scudeler, Thiago
Boeing Boros, Gustavo Andre
Ribas, Fernando Faglioni
Dallazen, Anderson Roberto
Favarato, Desiderio
Ramires, Jose
Kalil-Filho, Roberto
机构
[1] Hosp Clin HCFMUSP, Inst Coracao InCor, Sao Paulo, Brazil
[2] Univ Sao Paulo, Fac Med, Sao Paulo, Brazil
关键词
D O I
10.1016/S0735-1097(19)30716-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1177-381
引用
收藏
页码:108 / 108
页数:1
相关论文
共 50 条
  • [41] The variability of glycated hemoglobin is associated with renal function decline in patients with type 2 diabetes
    Lee, Chia-Lin
    Chen, Cheng-Hsu
    Wu, Ming-Ju
    Tsai, Shang-Feng
    THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2020, 11
  • [42] Apolipoprotein E polymorphism predicts cardiovascular events in patients with stable multivessel coronary artery disease
    Lopes, N. H.
    Ferri, L. A. F.
    Lima, E. G.
    Vieira, R. D.
    Soares, P. R.
    Cesar, L. A.
    Hueb, W.
    Kriger, J. E.
    Pereira, A. C.
    Ramires, J. A. F.
    EUROPEAN HEART JOURNAL, 2009, 30 : 63 - 63
  • [43] Coronary Revascularization Strategies in Patients With Diabetes and Multivessel Coronary Artery Disease
    Marso, Steven P.
    McGuire, Darren K.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 64 (12) : 1198 - 1201
  • [44] The impact of glycated hemoglobin A1c on cardiovascular risk in patients with and without coronary artery disease
    Olesen, K. K. W.
    Thrane, P. G.
    Hansen, M. K.
    Gyldenkerne, C.
    Maeng, M.
    EUROPEAN HEART JOURNAL, 2023, 44
  • [45] The hemoglobin glycation index predicts the risk of adverse cardiovascular events in coronary heart disease patients with type 2 diabetes mellitus
    Xu, Shuai
    Qin, Zhen
    Yuan, Ruixia
    Cui, Xiaolin
    Zhang, Li
    Bai, Jing
    Liu, Gangqiong
    Wang, Zeyu
    Yu, Fengyi
    Lv, Yan
    Zhang, Jinying
    Tang, Junnan
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [46] Chronic Kidney Disease, Type 2 Diabetes, and the Risk of Major Cardiovascular Events in Coronary Artery Disease vs. Peripheral Artery Disease Patients
    Sprenger, Lukas
    Maechler, Maximilian
    Vonbank, Alexander
    Larcher, Barbara
    Mader, Arthur
    Leiherer, Andreas
    Muendlein, Axel
    Drexel, Heinz
    Saely, Christoph H.
    DIABETES, 2022, 71
  • [47] Hemoglobin A1c Variability Metrics Predict Coronary Artery Calcium and Cardiovascular Events in Type 1 Diabetes: The CACTI Study
    Horton, William B.
    Snell-Bergeon, Janet K.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2023, 108 (07): : E444 - E449
  • [48] Glycated hemoglobin level and the severity of coronary artery disease
    Amin, A. E. H.
    Farrag, A. A. F.
    Ammar, W. A. A.
    EUROPEAN JOURNAL OF CARDIOVASCULAR NURSING, 2013, 12 : S4 - S4
  • [49] Impact of SGLT2 inhibitor on mortality and cardiovascular outcomes in patients with type 2 diabetes mellitus with left main or multivessel coronary artery disease
    Chipayo Gonzales, D. A.
    Salinas, P.
    Fuentes, M.
    Vergara, C.
    Espejo-Paeres, C.
    McInerney, A.
    Tirado-Conte, G.
    Macaya-Ten, F.
    Mejia-Renteria, H.
    Nunez-Gil, I.
    Gonzalo, N.
    Jimenez-Quevedo, P.
    Nombela-Franco, L.
    Escaned, J.
    Fernandez-Ortiz, A.
    EUROPEAN HEART JOURNAL, 2022, 43 : 2690 - 2690
  • [50] Glycated hemoglobin variability and microvascular complications in patients with type 1 diabetes mellitus
    Er, Eren
    Ata, Aysun
    Evin, Ferda
    Altinok, Yasemin Atik
    Demir, Gunay
    Ozen, Samim
    Darcan, Sukran
    Goksen, Damla
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2020, 33 (12): : 1533 - 1537